Search Results - Edith Dieleman

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Impaired survival and long-term neurological problems in benign meningioma

    Impaired survival and long-term neurological problems in benign meningioma by Hanna van Alkemade, Michelle de Leau, Edith Dieleman, J. W. P. F. Kardaun, Rob van Os, W. Peter Vandertop, Wouter R. van Furth, Lukas J.A. Stalpers

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)

    The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial) by Judi van Diessen, Dirk De Ruysscher, Jan‐Jakob Sonke, E. Damen, Karolina Sikorska, Bart Reymen, Wouter van Elmpt, Gunnar Westman, G. Persson, Edith Dieleman, Hedvig Björkestrand, Corinne Faivre‐Finn, J. Belderbos

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab by Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial

    18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial by Saskia A. Cooke, Dirk De Ruysscher, Bart Reymen, Maarten Lambrecht, G. Persson, Corinne Faivre‐Finn, Edith Dieleman, Rolf Lewensohn, Judi N.A. van Diessen, Karolina Sikorska, Ferry Lalezari, Wouter V. Vogel, Wouter van Elmpt, E. Damen, Jan‐Jakob Sonke, J. Belderbos

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)

    Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675) by J. Belderbos, Dirk K.M. De Ruysscher, Katrien De Jaeger, Friederike Koppe, Maarten Lambrecht, Yolande Lievens, Edith Dieleman, Jaap Jaspers, Jan P. van Meerbeeck, Fred Ubbels, Margriet Kwint, Marianne A. Kuenen, Sabine Deprez, Michiel B. de Ruiter, Willem Boogerd, Karolina Sikorska, Harm van Tinteren, Sanne B. Schagen

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial

    Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial by Martijn H. van der Ree, Edith Dieleman, J. Visser, R. Nils Planken, S. Matthijs Boekholdt, Rianne H A de Bruin-Bon, C. Rasch, Wiert F. Hoeksema, Rianne M A J de Jong, Michiel J. B. Kemme, Jippe C. Balt, Arthur A.M. Wilde, Brian V. Balgobind, Pieter G. Postema

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: